| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Strategy Officer | SVP Corporate Strategy | SVP Corporate Strategy
1 company
Trencher Daniel is a Chief Strategy Officer at Teladoc Health, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $238K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 2,000 | $160.30 | $320,600.00 | -7.8% | -16.9% | -74.5% | |
| Jun 10, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 2,000 | $150.07 | $300,140.00 | -7.8% | -9.4% | -79.4% | |
| May 10, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 2,000 | $150.00 | $300,000.00 | -7.8% | +6.7% | -78.9% | |
| Apr 12, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 2,000 | $181.00 | $362,000.00 | -12.1% | -14.3% | -63.3% | |
| Mar 10, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 3,000 | $196.30 | $588,900.00 | -20.7% | -24.0% | -70.1% | |
| Mar 5, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sell | 2,383 | $183.18 | $436,527.47 | -14.8% | - | - | |
| Mar 4, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 2,171 | $204.67 | $444,345.71 | -8.8% | - | - | |
| Mar 2, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 1,026 | $224.28 | $230,113.33 | -9.8% | - | - | |
| Feb 10, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 3,000 | $290.49 | $871,470.00 | -26.3% | - | - | |
| Jan 11, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 3,000 | $227.33 | $681,990.00 | -26.3% | - | - |